Genection Inc. Revolutionizing Genetic Testing

About Genection

Genection Inc., a venture by Invivoscribe Inc., is dedicated to simplifying access to comprehensive genetic testing for physicians worldwide. Based in San Diego, Genection provides a platform that offers a broad menu of clinically-actionable genetic tests, including cancer mutation testing and advanced sequencing options.

Services Offered

• Global Access: Physicians can order cancer somatic mutation testing through an easy-to-use online system.
• Non-Payor Driven: Genection ensures that genetic tests are available regardless of limitations from managed care plans.
• Integrated Services: Seamless integration with multiple CLIA- and CAP-accredited labs for test reporting and interpretation.

Industry Impact

Genection aims to reduce the administrative burden on clinicians by offering a consolidated approach to genetic testing, including:

• Next Generation Sequencing: Detecting driver mutations in cancer, aiding in personalized treatment plans.

Technology and Security

Web Application: The Genection platform facilitates team-based medical care by allowing sharing of genetic information among healthcare providers on a secure patient data management that complies with all relevant regulatory rules.

Initiatives

Together We Cure: A global platform for sharing clinical data among AML patients and physicians to accelerate the development of targeted therapies.

Leadership

Jeffrey E. Miller, PhD: Founder of Invivoscribe and now President of Genection, leading the charge in transforming personalized molecular medicine into clinical practice.